JESSICA TAYLOR: Open Payments
NPI 1184851776 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 22 payments from 8 companies in 2025. Trend: 2023 $490 · 2024 $577 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $198 |
| SHIELD THERAPEUTICS INC | 1 | $88 |
| ABBVIE INC. | 4 | $65 |
| GENZYME CORPORATION | 2 | $49 |
| Celltrion USA Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: ENTYVIO, ACCRUFER, DUPIXENT, RINVOQ, VEGZELMA, XIFAXAN, XELJANZ.
Industry payments across KS — which companies pay providers there.
